Publication | Open Access
Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery
107
Citations
18
References
2013
Year
These findings indicate that MSV/EphA2 merits further development as a novel therapeutic agent for ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1